Upgrade to SI Premium - Free Trial

Corbus Pharmaceuticals (CRBP) PT Lowered to $48 at Oppenheimer

August 7, 2026 8:04 AM
Oppenheimer analyst Jeff Jones lowered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change